|
Anticoagulants
Citations 61-70 of 77 total displayed.
|
Past content
(since Feb 1999):
|
- Articles
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
- Expert Panel/Writing Group, Lori Mosca, Lawrence J. Appel, Emelia J. Benjamin, Kathy Berra, Nisha Chandra-Strobos, Rosalind P. Fabunmi, Deborah Grady, Constance K. Haan, Sharonne N. Hayes, Debra R. Judelson, Nora L. Keenan, Patrick McBride, Suzanne Oparil, Pamela Ouyang, Mehmet C. Oz, Michael E. Mendelsohn, Richard C. Pasternak, Vivian W. Pinn, Rose Marie Robertson, Karin Schenck-Gustafsson, Cathy A. Sila, Sidney C. Smith, Jr, George Sopko, Anne L. Taylor, Brian W. Walsh, Nanette K. Wenger, and Christine L. Williams
Circulation published February 4, 2004, doi:10.1161/01.CIR.0000114834.85476.81
[Abstract]
- Clinical Investigations and Reports
Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation
- Dwayne S.G. Conway, Lesly A. Pearce, Bernard S.P. Chin, Robert G. Hart, and Gregory Y.H. Lip
Circulation 2003;107:3141-3145; published online before print as doi:10.1161/01.CIR.0000077912.12202.FC
[Abstract]
[Full text]
- Clinical Investigations and Reports
Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation
- Dwayne S.G. Conway, Lesly A. Pearce, Bernard S.P. Chin, Robert G. Hart, and Gregory Y.H. Lip
Circulation published June 9, 2003, doi:10.1161/01.CIR.0000077912.12202.FC
[Abstract]
[Full text]
- Correspondence
Patent Foramen Ovale and Cryptogenic Stroke: The Controversy Continues • Response
- David James McGaw, Antony Marcello Ugoni, Shunichi Homma, Robert R. Sciacca, Marco R. Di Tullio, John L. Thompson, Bruce Levin, Ralph L. Sacco, and J.P. Mohr
Circulation 2003;107:e51, doi:10.1161/01.CIR.0000055540.22976.6C
[Full text]
- Clinical Cardiology: New Frontiers
Treatment of Acute Ischemic Stroke: Part II: Neuroprotection and Medical Management
- Joseph P. Broderick and Werner Hacke
Circulation 2002;106:1736-1740, doi:10.1161/01.CIR.0000030407.10591.35
[Full text]
- Cardiology Patient Pages
Atrial Fibrillation
- Johan E.P. Waktare
Circulation 2002;106:14-16, doi:10.1161/01.CIR.0000022730.66617.D9
[Full text]
- Editorials
Patent Foramen Ovale and Recurrent Stroke: Another Paradoxical Twist
- Jonathan L. Halperin and Valentin Fuster
Circulation 2002;105:2580-2582, doi:10.1161/01.CIR.0000020353.63751.2F
[Full text]
- Clinical Investigations and Reports
Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale: Patent Foramen Ovale in Cryptogenic Stroke Study
- Shunichi Homma, Ralph L. Sacco, Marco R. Di Tullio, Robert R. Sciacca, J.P. Mohr for the PFO in Cryptogenic Stroke Study (PICSS) Investigators
Circulation 2002;105:2625-2631; published online before print as doi:10.1161/01.CIR.0000017498.88393.44
[Abstract]
[Full text]
- Articles
Effect of Medical Treatment in Stroke Patients
With Patent Foramen Ovale. Patent Foramen Ovale in Cryptogenic Stroke
Study
- Shunichi Homma, Ralph L. Sacco, Marco R. Di Tullio, Robert R. Sciacca, J. P. Mohr for
the PFO in Cryptogenic Stroke Study (PICSS)
Investigators
Circulation published May 13, 2002, doi:10.1161/01.CIR.0000017498.88393.44
[Abstract]
- Correspondence
Implications of Stroke Risk Criteria on the Anticoagulation Decision in Nonvalvular Atrial Fibrillation
- Paul A. Tunick and Itzhak Kronzon
Circulation 2001;103:e79
[Full text]
|
|
